微泰医疗器械（杭州）股份有限公司（02235）于2025年11月28日更新翌日披露报表，披露了一次股份回购交易。本次回购于同日进行，涉及31,100股H股，回购价格区间介乎每股6.64港元至6.80港元，合计动用资金约20.95万港元。
本次交易占回购前公司已发行股本（不含库存股）约0.0187%。回购完成后，微泰医疗器械（杭州）股份有限公司的已发行股份总数维持在169,175,842股，其中166,274,342股为流通股，2,901,500股为库存股。本次回购基于2025年5月28日通过的股份购回授权，授权可回购股份总数为16,668,364股，公司迄今已累计回购349,300股，占授权通过时已发行股本的0.2096%。
公司同时确认，相关程序均已履行并符合香港联交所证券上市规则及其他适用法规要求。上述公告由执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.